Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      Home/Newsroom/Neuroscience

      Neuroscience latest news

      Neuroscience
      Johnson & Johnson highlights innovative neuropsychiatry portfolio and pipeline at Psych Congress
      October 24, 2024
      Read more
      Neuroscience
      Nipocalimab demonstrates sustained disease control in adolescents living with generalized myasthenia gravis in Phase 2/3 study
      October 15, 2024
      United States
      Read more
      Neuroscience
      Johnson & Johnson showcases innovation and commitment to people living with gMG, presenting 25 abstracts at AANEM Annual Meeting and MGFA Scientific Session
      October 3, 2024
      United States
      Read more
      Neuroscience
      Groundbreaking nipocalimab study of pregnant individuals at high risk for early onset severe hemolytic disease of the fetus and newborn published in The New England Journal of Medicine
      August 7, 2024
      United States
      Read more
      Neuroscience
      Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with treatment-resistant depression
      July 22, 2024
      United States
      Read more